Location History:
- Waltham, MA (US) (2018)
- San Mateo, CA (US) (2022 - 2024)
Company Filing History:
5 out of 18 
2 out of 4 
1 out of 18 Years Active: 2018-2025
Title: Chris P Miller: A Pioneer in Breast Cancer Treatment Innovations
Introduction
Chris P Miller, an accomplished inventor based in Waltham, MA, has made significant contributions to the field of cancer treatment. With six patents to his name, he is recognized for his innovative approaches to addressing complex medical challenges. His work is particularly focused on advancements in breast cancer treatment.
Latest Patents
Among his latest patents, Miller has developed methods for treating AR+ breast cancer. This innovative technique involves the administration of an AR agonist, such as SARMs like RAD140, often in combination with various therapeutic agents including CDK4/6 inhibitors, m-TOR inhibitors, PI3K inhibitors, PARP inhibitors, BCL-2 inhibitors, and MCL-1 inhibitors. Additionally, he has patented compounds that act as estrogen receptor modulators. These compounds are described as having pharmaceutical compositions and methods to treat diseases mediated by estrogen receptors, both alone and in combination with other therapies.
Career Highlights
Miller has built a robust career in the pharmaceutical industry, contributing to significant advancements in cancer therapeutics. He has held key positions at notable companies such as Radius Pharmaceuticals and Ellipses Pharma. His experience in these organizations has equipped him with the necessary skills and knowledge to drive innovation in his field.
Collaborations
Throughout his career, Chris Miller has collaborated with other experts in the industry, including Gary Hattersley and Jamal Saeh. These partnerships have allowed for the exchange of ideas and have fostered an environment conducive to groundbreaking research and development.
Conclusion
As an inventor dedicated to improving cancer treatment methods, Chris P Miller stands out for his innovative contributions to medical science. His latest patents reflect a commitment to addressing the challenges associated with AR+ breast cancer and signify a step forward in the development of effective treatments. With a remarkable career and collaborative spirit, Miller continues to be an influential figure in the realm of pharmaceutical innovations.